Clinical Trials Logo

Clinical Trial Summary

To study the correlation between the polymorphism of the main immunity genes and progression-free survival in ALCL of the child.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02902874
Study type Interventional
Source Gustave Roussy, Cancer Campus, Grand Paris
Contact
Status Completed
Phase N/A
Start date April 21, 2010
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT04021082 - CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Phase 2/Phase 3
Recruiting NCT05160922 - Crizotinib Continuation Clinical Study Phase 4